# Exercise on Ozempic, Wegovy, or Mounjaro: Why Resistance-Engaging Cardio Matters **By Aviron · Published May 11, 2026 · Updated May 14, 2026** Learn why resistance-engaging cardio matters during GLP-1 weight loss, how lean tissue changes, and why rowing can fit a sustainable exercise routine. > This is educational content, not medical advice. Always talk to your doctor before starting a new exercise routine. --- ## Overview GLP-1 medications — semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — are producing significant weight loss results. On a GLP-1, roughly 25% of weight lost is lean tissue, not fat. The kind of exercise you choose changes how much muscle you keep. In Gallup's mid-2025 polling, 12.4% of US adults reported taking a GLP-1 for weight loss, more than double the 5.8% rate from early 2024. Clinical trial results explain the demand: - STEP-1 patients on semaglutide lost an average of 14.9% of body weight over 68 weeks (Wilding et al., NEJM 2021) - SURMOUNT-1 patients on the highest dose of tirzepatide lost 20.9% over 72 weeks (Jastreboff et al., NEJM 2022) Those are numbers that historically required bariatric surgery. But the scale only tells part of the story. What tissue you're losing alongside the fat is where exercise comes in — and not just any exercise. --- ## What Happens to Your Muscles on a GLP-1? Weight lost on a GLP-1 is not uniformly fat. Published DXA body-composition substudies have quantified the split, and the pattern holds across drug, dose, and population. **STEP-1 DXA substudy** (n=140, semaglutide 2.4 mg, 68 weeks): - Total body weight lost: 15.0% - Fat mass dropped: 19.3% - Visceral fat dropped: 27.4% - Lean body mass dropped: 9.7% in absolute terms (Wilding et al., Diabetes Obes Metab 2021) **SURMOUNT-1 body-composition substudy** (tirzepatide, 72 weeks): - Total weight: -21.3% - Fat mass: -33.9% - Lean mass: -10.9% - Roughly 75% of weight lost was fat, 25% was lean tissue — consistent across age, sex, and weight-loss subgroups in both drug arms and the placebo arm (Look et al., Diabetes Obes Metab 2025) **SELECT trial** (semaglutide in cardiovascular patients, n=17,604): About a third of the 20% MACE reduction was mediated by waist-circumference change, with a 4% lower MACE risk per 5 cm reduction (Lincoff et al., NEJM 2023; SELECT body-composition subanalysis, 2025). A 2024 review in Diabetes, Obesity and Metabolism adds useful context: "lean body mass" on DXA includes organs, bone, and water, not just skeletal muscle. Some MRI-based work suggests muscle quality can improve (less fat infiltration, better insulin sensitivity) even as volume drops. The research is nuanced, but the headline finding — meaningful lean-tissue loss alongside fat loss — is consistent across trials. Importantly, this ~25% lean-mass share of weight loss is similar to what happens with caloric restriction alone (Weinheimer et al., 2010 systematic review of 52 studies). GLP-1s aren't uniquely bad for muscle. Losing weight is what's hard on muscle. The question is what you do about it. --- ## Why Does Muscle Loss Matter Beyond the Mirror? Skeletal muscle is metabolically and structurally load-bearing, not just aesthetic. - **Resting metabolic rate.** Muscle is more metabolically active than fat at rest. Less muscle means a lower floor on daily calorie burn, which compounds over years and makes weight maintenance harder after the medication or the deficit ends. - **Bone density.** In the Villareal NEJM 2017 trial of obese older adults losing weight, the aerobic-only group lost roughly 3% of hip BMD over 26 weeks. The resistance-training groups lost far less (Villareal et al., NEJM 2017). Rapid weight loss without loading is hard on bone. - **Functional capacity.** Getting up off the floor, carrying groceries, climbing stairs — these draw on lower-body and posterior-chain strength. Losing that capacity in your 40s or 50s has a long tail. - **Long-term maintenance.** The more muscle mass you preserve, the better your chances of keeping weight off if you cycle off the medication. More muscle means higher daily expenditure and more wiggle room on intake. ### What Major Guideline Bodies Now Recommend - **American Diabetes Association 2025 Standards of Care:** Explicitly emphasize meeting resistance-training guidelines and adequate protein intake for patients on weight-management pharmacotherapy. - **WHO's first-ever GLP-1 guideline (December 2025):** Includes a conditional recommendation that structured physical activity accompany GLP-1 pharmacotherapy. - **EASO (European Association for the Study of Obesity):** Recommends 200–300 minutes per week of aerobic activity plus moderate-to-high-intensity resistance training for people managing obesity. Structured, resistance-loaded exercise is part of the standard of care — not an optional add-on. --- ## What Does the Research Say About Exercise During GLP-1 Weight Loss? Resistance-loaded exercise preserves more lean mass during a deficit than low-load cardio alone. - **Villareal et al., NEJM 2017:** Randomized 160 obese older adults to 26 weeks of weight loss plus exercise. The aerobic-only group lost 5% of lean mass. The resistance-only group lost only 2%. The combined aerobic + resistance group lost 3% but showed the biggest functional gains (physical performance test +21%). Conclusion: combined training best preserved function during weight loss. - **Longland et al., AJCN 2016:** Compared higher protein (2.4 g/kg/day) versus moderate protein (1.2 g/kg/day) in young men during a 4-week deficit with resistance training and HIIT six days per week. The high-protein group gained 1.2 kg of lean mass while in a deficit; the control group held steady. Protein intake matters alongside the training stimulus. - **Weinheimer et al., 2010:** A systematic review of 52 studies in adults 50+ found that energy restriction alone led to substantial fat-free-mass loss in the majority of studies reviewed, and that adding exercise roughly halved the rate of excess lean-mass loss. - **Murphy & Koehler, Scand J Med Sci Sports 2022:** Reviewed resistance-trained athletes in caloric deficits and found that maintaining resistance-training volume during a deficit protects lean mass; programs with a sustained training stimulus outperformed reduced-volume approaches. The pattern is consistent: medication handles the deficit, exercise protects the tissue and improves metabolic quality. --- ## Why Does Rowing Fit the GLP-1 Use Case? There is no RCT directly comparing rowing to treadmill walking, cycling, or dedicated strength training in a GLP-1 cohort. The case for rowing is a mechanism-stacking argument, not a head-to-head claim. 1. **Full-body resistance engagement.** A rowing stroke is roughly 60% legs, 30% core, 10% arms. Every stroke loads the posterior chain — glutes, hamstrings, spinal erectors, lats — under resistance. That's different from cycling (quad-dominant, low external load) or treadmill walking (mostly bodyweight cardio). Rowing doesn't replace heavy compound lifting, but its resistance component is substantially higher than typical steady-state cardio. 2. **Low-impact.** GLP-1 users often enter exercise deconditioned and at higher BMI, and body weight can change quickly. Rowing is non-weight-bearing at the impact level — no ground reaction forces pounding through knees and hips. This aligns with the ACSM's 2024 position on physical activity in medical weight management, which emphasizes progressive, individualized programming for deconditioned starters. 3. **Scalable.** On an air-and-magnetic resistance rower, the intensity is set by how hard you pull. A deconditioned beginner can row gently at 2 out of 10 in the first week. Four months in, the same machine is still challenging. That matters during a multi-year body-composition project. 4. **Efficient.** A rowing stroke recruits a large amount of muscle mass simultaneously, producing a high VO2 demand in a short window. GLP-1 fatigue — especially in dose-escalation weeks — is real. When you have twenty good minutes, a modality that delivers full-body work in that window is practical. 5. **Accessible for people who haven't exercised in years.** The seated, self-paced stroke, the ability to stop whenever, and the option to row at a conversational pace all lower the activation energy. Many GLP-1 patients are returning to exercise after a long gap. **What this article will not claim:** that rowing uniquely prevents GLP-1 muscle loss, that it outperforms dedicated resistance training for hypertrophy, or that it's clinically recommended over other modalities. None of those claims have RCT support. What rowing does offer is a low-impact, full-body, resistance-engaging cardio modality that checks more of the muscle-preservation boxes than treadmill walking or cycling alone, and that many people find sustainable. --- ## What Are Other Fitness Brands Saying About GLP-1 Exercise? Aviron isn't first to this conversation: - **Hydrow** has two GLP-1-specific articles (one on combating muscle loss, one a user testimonial). - **NordicTrack** has the most aggressive content program in the category, with five articles covering GLP-1 and strength training, GLP-1 fatigue management, and nutrition. - **iFit** has launched a coached "GLP-1 Strength Support Series." - **Tonal** is positioning itself as the muscle-preservation answer to GLP-1 weight loss in its 2026 predictions content. The fact that the equipment category has moved on this reflects real demand: people on GLP-1s are looking for exercise guidance, and they're looking for it in the places they buy equipment. This article is Aviron's entry into that conversation, built on the angle of resistance-engaging cardio specifically — low-impact enough for deconditioned starters, scalable enough to grow into. --- ## Which Rowing Machine Should You Use on a GLP-1? ### Aviron Strong Series Rower — $1,999 The Strong Series Rower is built for the multi-year body-composition project a GLP-1 protocol demands. - **30-day in-home trial** - **$29/month family membership** — unlimited profiles (relevant because if you're on a GLP-1, it's fairly common that someone else in the household is also trying to get healthier, and adding a second, third, or fourth profile doesn't cost extra) - **HSA/FSA eligible** - **Financing available** - **Standard free shipping** across the contiguous US and Canada **Specs relevant to the GLP-1 use case:** | Feature | Detail | |---|---| | Resistance | Dual air + magnetic, up to 100 lbs | | Muscles engaged per stroke | 86% | | Weight capacity | 507 lbs | | User height range | Up to 6'8" | | Workouts available | 1,000+ (coached classes, fitness entertainment games, scenic rows, multiplayer) | | Platform stats | 4M+ workouts delivered, 50K+ members, 92% one-year retention rate | | Display | Rotating HD touchscreen | | Streaming | Netflix, Disney+, HBO Max, Spotify, and more | | Frame/parts/electronics warranty | 20 years while membership is active | The honest version: if you're adding a resistance-engaging cardio modality to your routine while on a GLP-1, this is a credible piece of equipment to do it on, with a trial window that lets you find out whether rowing actually fits your life before committing. --- ## What Should You Know Before You Start? - **Talk to your doctor first.** GLP-1s are a medical tool. Consult your doctor or prescribing clinician before starting any exercise program, especially in the first weeks of starting or dose-escalating. They know your cardiovascular history, your medication interactions, and your baseline. - **Side effects are real.** Nausea, fatigue, and reduced appetite — particularly during dose escalations — can make workouts harder. Start conservatively. Short, easy sessions that you actually complete beat ambitious sessions that you skip. - **Hydration and protein matter.** Adequate protein intake is consistently flagged by the ADA, EASO, and joint advisories (ACLM/ASN/OMA/TOS, AJCN/Obesity 2025) as a foundational support for lean-mass preservation during weight loss. Your clinician or a registered dietitian can personalize the target. - **Rowing has a learning curve.** The first two weeks feel awkward. Form matters: legs, then back, then arms on the drive; arms, then back, then legs on the recovery. Use the onboarding content. - **This is about what you keep, not what you lose.** Nothing in this article is a weight-loss claim. The medication does the weight loss. Exercise is about body composition, function, bone, and metabolic quality — the things the scale doesn't measure. --- ## Getting Started The Strong Series Rower is $1,999 with a 30-day trial — enough time to know whether rowing fits your life before you commit. The $29/month family membership covers unlimited profiles, which matters if more than one person in the household is working on their health. Talk to your doctor first. Then start slow. Then show up. --- ## Related Reading [The Complete Beginner's Guide to Using a Rowing Machine] : https://www.avironactive.com/blog/the-complete-beginner-s-guide-to-using-a-rowing-machine/ --- **Canonical URL:** https://www.avironactive.com/blog/exercise-on-ozempic-wegovy-mounjaro/